Clinical trials
alpha 1-Antitrypsin Deficiency trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Terminated | 3 |
| Unknown status | 3 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schön Klinik Berchtesgadener Land | 3 |
| University of North Carolina, Chapel Hill | 2 |
| Ariel University | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
| Heidelberg University | 1 |
| Hospital Universitari Vall d'Hebron Research Institute | 1 |
| McMaster University | 1 |
| University Hospital, Saarland | 1 |
| University of Florida | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| alpha 1-Antitrypsin Deficiency | 12 |
| Pulmonary Disease, Chronic Obstructive | 8 |
| Emphysema | 5 |
| Bronchiectasis | 4 |
| Pulmonary Fibrosis | 3 |
| Cystic Fibrosis | 2 |
| Hypertension, Pulmonary | 2 |
| Sarcoidosis | 2 |
| Asthma | 1 |
| Bronchopulmonary Dysplasia | 1 |
Trials
Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.